Gut bacterial metabolite Urolithin A inhibits myocardial fibrosis through activation of Nrf2 pathway in vitro and in vivo
Authors:
Open Access
- 8 February 2022
- journal article
- research article
- Published by Springer Nature in Molecular Medicine
- Vol. 28 (1) , 1-10
Abstract
Background: Myocardial fibrosis after myocardial infarction (MI) is one of the leading causes of cardiovascular diseases. Cardiac fibroblasts (CFs) are activated and promoted by MI to undergo myofibroblast transformation (CMT). Urolithin A (UA) is an active and effective gut metabolite derived from polyphenolics of berries and pomegranate fruits, which has been reported to have anti-inflammatory and anti-oxidant functions. However, whether UA affects the CMT process during myocardial fibrosis remains unclear. Methods: TGF-β1-treated primary rat cardiac fibroblasts were used for in vitro study. Cell proliferation ability was evaluated by MTT assay. Cell migration and invasion abilities were tested by wound healing and Transwell assays. The expression of CMT process-related markers were measured by qRT-PCR and western blot. The rat MI model was established by left anterior descending coronary artery (LAD) ligation and evaluated by H&E and Masson staining. Results: Our data demonstrated that UA treatment could inhibit the CMT process in TGF-β1-induced CFs, including cell proliferation, migration and invasion abilities. Knocking down of Nrf2, which was activated by UA treatment, could mitigate the effects of UA treatment on CMT process. Moreover, in vivo administration of UA in rat MI model successfully up-regulated Nrf2 expression and improved the myocardial damage and fibrosis. Conclusions: The study discovered the function and mechanism of UA on myocardial fibrosis and demonstrated the protective effects of UA administration through activation of Nrf2 pathway.Keywords
Funding Information
- Strategic cooperation projects about the innovation and application of cardiovascular medical technology
This publication has 30 references indexed in Scilit:
- Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathwayJournal of Molecular and Cellular Cardiology, 2014
- Fibroblasts in post-infarction inflammation and cardiac repairBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2013
- Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So FarEvidence-Based Complementary and Alternative Medicine, 2013
- Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and ApoptosisEvidence-Based Complementary and Alternative Medicine, 2013
- The Notch pathway controls fibrotic and regenerative repair in the adult heartEuropean Heart Journal, 2012
- The transcription factor NF‐E2‐related Factor 2 (Nrf2): a protooncogene?The FASEB Journal, 2012
- Left ventricular remodeling in the post-infarction heart: a review of cellular, molecular mechanisms, and therapeutic modalitiesHeart Failure Reviews, 2010
- The Nrf2-Antioxidant Response Element Signaling Pathway and Its Activation by Oxidative StressJournal of Biological Chemistry, 2009
- Oxidative stress and redox signalling in cardiac hypertrophy and heart failureHeart, 2006
- Identification of Urolithin A as a Metabolite Produced by Human Colon Microflora from Ellagic Acid and Related CompoundsJournal of Agricultural and Food Chemistry, 2005